Liminatus Pharma (LIMN) Stock: Nasdaq delisting warning sparks volatile trading session
Key points LIMN shares jumped 31% after Nasdaq was notified of the delisting, although pre-market sessions saw sharp reversals. The company falls short of Nasdaq’s $50 million market cap and $15 million public float threshold. Liminatus has until May 27…







